IP and COVID: A Story of Innovation in the Midst of Crisis
Date & Time:
9th Dec 2021
3:00pm ThuAdd to calendar
GenevaView on maps
Following the outbreak of the Covid-19 pandemic in 2020, many countries around the world have proposed a temporary waiver of Intellectual Property (IP) rights on pharmaceutical and public health products, with the aim of increasing availability to vaccines and other crucial products in this time of emergency. A look back at the course of events that produced the current landscape of successful vaccines, however, raises doubts about the practicability and potential benefits of waiving property protections in the midst of a crisis. This panel will discuss the industry landscape that created the world’s successful vaccines, and the role that intellectual property played in their history, design, manufacture, and distribution.